Introducing Tempus One in the EHR with Integrated Guidelines
CHICAGO--(BUSINESS WIRE)--Jun 1, 2025--
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the expansion of Tempus One—its generative AI clinical assistant—with direct integration into electronic health record (EHR) systems. By integrating AI at every point of the clinical care process, the expanded capabilities of Tempus One offer physicians in oncology and beyond more support in treatment decisions. Tempus One is uniquely positioned to offer these new features given the company's depth and scale of EHR integrations with providers across the U.S.
Tempus has developed an integrated architecture that captures real-time clinical, molecular and imaging data from millions of patients and makes that data easily digestible and useful for clinicians and care teams. Through Tempus One, physicians can gain AI-enabled insights that transform how they interact with patient data, streamlining complex treatment decisions and reducing time spent on administrative tasks.
New capabilities in the latest iteration of Tempus One:
'As healthcare faces rising costs and growing complexity, no group bears the burden more heavily than physicians and care teams,' said Ryan Fukushima, Chief Operating Officer at Tempus. 'This evolution of Tempus One represents a meaningful shift from a world where clinicians spend countless hours searching for answers and documenting care, to one where AI rapidly connects the dots across fragmented systems to deliver actionable insights in real time.'
To learn more about Tempus One, view a video here and visit the website here.
About Tempus
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world's largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the 'Securities Act'), and Section 21E of the Securities Exchange Act of 1934, as amended, about Tempus and Tempus' industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release are forward-looking statements, including, but not limited to, statements regarding the expected outcomes and benefits of Tempus One and its capabilities for customers. In some cases, you can identify forward-looking statements because they contain words such as 'anticipate,' 'believe,' 'contemplate,' 'continue,' 'could,' 'estimate,' 'expect,' 'going to,' 'intend,' 'may,' 'plan,' 'potential,' 'predict,' 'project,' 'should,' 'target,' 'will,' or 'would' or the negative of these words or other similar terms or expressions. Tempus cautions you that the foregoing may not include all of the forward-looking statements made in this press release.
You should not rely on forward-looking statements as predictions of future events. Tempus has based the forward-looking statements contained in this press release primarily on its current expectations and projections about future events and trends that it believes may affect Tempus' business, financial condition, results of operations and prospects. These forward-looking statements are subject to risks and uncertainties related to: Tempus' financial performance; the ability to attract and retain customers and partners; managing Tempus' growth and future expenses; competition and new market entrants; compliance with new laws, regulations and executive actions, including any evolving regulations in the artificial intelligence space; the ability to maintain, protect and enhance Tempus' intellectual property; the ability to attract and retain qualified team members and key personnel; the ability to repay or refinance outstanding debt, or to access additional financing; future acquisitions, divestitures or investments; the potential adverse impact of climate change, natural disasters, health epidemics, macroeconomic conditions, and war or other armed conflict, as well as risks, uncertainties, and other factors described in the section titled 'Risk Factors' in Tempus' Annual Report on Form 10-K for the year ended December 31, 2024, filed with the Securities and Exchange Commission ('SEC') on February 24, 2025, as well as in other filings Tempus may make with the SEC in the future. In addition, any forward-looking statements contained in this press release are based on assumptions that Tempus believes to be reasonable as of this date. Tempus undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250601970190/en/
CONTACT: Erin Carron
[email protected]
KEYWORD: ILLINOIS UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: APPS/APPLICATIONS TECHNOLOGY HEALTH TECHNOLOGY SOFTWARE NETWORKS HEALTH GENERAL HEALTH ARTIFICIAL INTELLIGENCE ONCOLOGY
SOURCE: Tempus AI, Inc.
Copyright Business Wire 2025.
PUB: 06/01/2025 08:30 AM/DISC: 06/01/2025 08:31 AM
http://www.businesswire.com/news/home/20250601970190/en
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
30 minutes ago
- Yahoo
Top Steelers NFL draft prospect LaNorris Sellers passes up huge NIL deal
The top priority of the Pittsburgh Steelers scouting staff this college football season is to sort out what is already shaping up to be an elite quarterback class for the 2026 NFL draft. Thanks to the ridiculous nature of NIL money, the NFL now has another aspect of players to track and that's their loyalty to their team as opposed to making fast money in college football. One of the top quarterback prospects in the upcoming draft is LaNorris Sellers out of South Carolina. News came out about Sellers this week and thanks to some intervention by his dad, Sellers chose to pass up $8 million over two years in NIL money to stay. According to Sellers' dad, there were multiple schools bidding for his services, but he showed maturity and loyalty by staying, which is a huge green flag for an NFL team. Advertisement From a football standpoint, Sellers is poised for a huge breakout season. His athleticism and mobility are already off the charts and as the season progressed, we saw his pocket presence and processing speed improve drastically down the stretch. Sellers and Clemson's Cade Klubnik are my top two options for the Steelers and this move by Sellers just helps his case. This article originally appeared on Steelers Wire: Steelers NFL draft prospect LaNorris Sellers passes up huge NIL deal
Yahoo
31 minutes ago
- Yahoo
Franklin County home listings asked for more money in May - see the current median price here
The median home in Franklin County listed for $364,900 in May, up 1.2% from the previous month's $360,720, an analysis of data from shows. Compared to May 2024, the median home list price increased 13.2% from $324,723. The statistics in this article only pertain to houses listed for sale in Franklin County, not houses that were sold. Information on your local housing market, along with other useful community data, is available at Franklin County's median home was 1,968 square feet, listed at $183 per square foot. The price per square foot of homes for sale is up 2.2% from May 2024. Listings in Franklin County moved briskly, at a median 36 days listed compared to the May national median of 51 days on the market. In the previous month, homes had a median of 38 days on the market. Around 196 homes were newly listed on the market in May, a 7.7% increase from 182 new listings in May 2024. The median home prices issued by may exclude many, or even most, of a market's homes. The price and volume represent only single-family homes, condominiums or townhomes. They include existing homes, but exclude most new construction as well as pending and contingent sales. In Pennsylvania, median home prices were $325,000, a slight increase from April. The median Pennsylvania home listed for sale had 1,708 square feet, with a price of $196 per square foot. Throughout the United States, the median home price was $440,000, a slight increase from the month prior. The median American home for sale was listed at 1,840 square feet, with a price of $234 per square foot. The median home list price used in this report represents the midway point of all the houses or units listed over the given period of time. Experts say the median offers a more accurate view of what's happening in a market than the average list price, which would mean taking the sum of all listing prices then dividing by the number of homes sold. The average can be skewed by one particularly low or high price. The USA TODAY Network is publishing localized versions of this story on its news sites across the country, generated with data from Please leave any feedback or corrections for this story here. This story was written by Ozge Terzioglu. Our News Automation and AI team would like to hear from you. Take this survey and share your thoughts with us. This article originally appeared on Waynesboro Record Herald: Franklin County home listings asked for more money in May - see the current median price here
Yahoo
32 minutes ago
- Yahoo
Trust in AI is growing in finance, especially behind the scenes
This story was originally published on CX Dive. To receive daily news and insights, subscribe to our free daily CX Dive newsletter. A majority of customers trust the use of AI in behind-the-scenes tasks at financial institutions, according to a TD Bank survey conducted by Ipsos released Tuesday. Among the 2,500 U.S. consumers polled, 70% are comfortable with technology being used for fraud detection, and 64% are comfortable with it being used in credit score calculations. Consumers also believe that AI should offer more ease. Two-thirds believe it can expand access to financial tools, and nearly half expect benefits from AI like 24/7 banking access. As consumers have become more familiar with AI tools, their trust in the technology has slowly grown. Nearly 7 in 10 consumers say they are at least somewhat familiar with AI — a finding seen in other surveys, too. Notably, half of consumers trust that AI will provide reliable, competent information, trusting AI just as much as news stations. But consumers are more comfortable with AI in specific use cases and the more complex or sensitive the matter, the more they want to speak to a human or know that a human will be reviewing AI before making any decisions. Consumers are less inclined to want to only use AI when it comes to tasks that one might typically use a financial adviser for, according Ted Paris, EVP, TD Bank AMCB, and head of analytics, intelligence & AI. When it comes to personal finance, 3 in 5 of consumers were comfortable with the idea of using AI financial tools for budgeting and automating savings goals. But less than half were comfortable with more complex tasks like retirement planning and investing. Banks enjoy high consumer trust — more than 4 in 5 consumers trust banks for accurate information. As they deploy AI, it's important that they maintain that, Paris said. 'What's probably the key piece, is creating and enabling and allowing customers and colleagues to feel that they can trust the outcomes of what this capability then generates,' Paris said. One of the ways TD Bank is approaching this is by always having a human in the loop, meaning that the output of an AI solution will be passed through some internal expert before going to a client. 'We need to make sure that first, anything that we're doing is directed toward a particular need,' Paris said. 'We need to make sure that this is going to meet all hurdles that we would set, legal, regulatory, for security and privacy.' Sign in to access your portfolio
